University of Cambridge at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Cambridge takes part in 7 sessions at ESMO 2026 in Madrid. Its program ranges from early detection of oesophageal cancer to generative artificial intelligence and AI-based biomarkers in precision medicine. Other sessions cover rare genitourinary cancers, treatment around surgery for urothelial and kidney cancer, and immune profiling of early triple-negative breast cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Cambridge Cambridge, United Kingdom | |
Public research university in Cambridge, United Kingdom, with a clinical school and cancer research institutes. | Keynote Fri Oct 23 11:48–11:58 Talk Fri Oct 23 14:15–14:30 Chair Sat Oct 24 14:45–16:15 Rare GU cancers Genitourinary cancers Talk Sun Oct 25 15:15–16:00 Chair Sun Oct 25 16:30–18:00 Peri-operative management of urothelial cancer Genitourinary cancers Talk Sun Oct 25 17:30–17:45 Reflection and implications for kidney cancer Genitourinary cancers Abstract Mon Oct 26 14:45–14:55 Talk Tue Oct 27 09:40–10:00 |
Instantly find 20 buyers from University of Cambridge
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction